Filter
13011
Filtered Results: 13011
Text search:
development
Featured
Recommendations
972
New Publications
3334
Language
Document type
No document type
7429
Studies & Reports
2285
Guidelines
1379
Manuals
581
Strategic & Response Plan
445
Fact sheets
331
Training Material
228
Situation Updates
111
Resource Platforms
80
Infographics
66
Brochures
35
Online Courses
24
Videos
10
Dashboards/Maps
4
App
3
Countries / Regions
Global
565
India
490
Kenya
361
Ethiopia
272
Nepal
257
South Africa
240
Myanmar / Burma
236
Sierra Leone
235
Uganda
234
Nigeria
228
Liberia
205
Western and Central Europe
199
Rwanda
181
Malawi
180
Latin America and the Carribbean
179
Africa
172
Zambia
170
Bangladesh
169
Tanzania
158
Syria
148
Indonesia
140
Ukraine
140
Ghana
136
Congo, Democratic Republic of
133
Philippines
112
Namibia
97
Senegal
95
Eastern Europe
91
Lesotho
89
Russia
89
Zimbabwe
86
South Sudan
86
Mozambique
86
Cambodia
83
South–East Asia Region
77
Haiti
76
Guinea
73
Burkina Faso
71
Asia
70
Yemen
67
Germany
66
West and Central Africa
66
Brazil
63
East and Southern Africa
61
Middle East and North Africa
57
Venezuela
55
Cameroon
52
Botswana
51
Colombia
48
Benin
46
Eastern Europe and Central Asia
44
Afghanistan
40
Eswatini/ Swaziland
39
Pakistan
37
Central African Republic
34
Lebanon
32
Sudan
32
Madagascar
29
Jordan
28
Mali
26
Somalia
26
Western Pacific Region
26
Paraguay
26
Thailand
24
Vietnam
24
Peru
23
Argentina
22
USA
21
Iraq
20
China
20
Tajikistan
20
Côte d’Ivoire / Ivory Coast
17
Moldova
17
Angola
15
Chile
15
Albania
15
Ecuador
14
Sri Lanka
14
Niger
13
Togo
12
Turkey
12
Libya
12
Laos
12
Palestine
11
Papua New Guinea
10
Georgia
10
Egypt
9
Burundi
9
Mexico
9
Southern Africa
9
Iran
9
North America
9
Guinea-Bissau
8
Chad
8
North Macedonia
8
Bolivia
8
Kyrgyzstan
8
United Kingdom
8
Honduras
7
Poland
7
Armenia
7
Kazakhstan
7
Jamaica
7
Portugal
7
Gambia
6
Hungary
6
El Salvador
6
Guatemala
6
Bhutan
6
Romania
6
Spain
6
Saudi Arabia
5
Malaysia
5
Canada
5
Timor Leste/ East Timor
5
Turkmenistan
5
Japan
5
Tunisia
5
Morocco
4
Serbia
4
Greece
4
Fiji
4
Uzbekistan
4
Belarus
4
Singapore
3
Croatia
3
Nicaragua
3
Djibouti
3
Congo-Brazzaville
3
Estonia
3
France
3
Mauritius
3
Bosnia and Herzegovina
3
Mauritania
2
Vanuatu
2
Dominican Republic
2
Other region
2
North Korea
2
Italy
2
Mongolia
2
Qatar
2
Bulgaria
2
Lithuania
2
Slovakia
2
Gabon
2
Belgium
2
Algeria
2
Azerbaijan
2
Israel
2
Ireland
1
Switzerland
1
Luxembourg
1
Solomon Islands
1
Australia
1
Uruguay
1
Denmark
1
Maldives
1
Norway
1
French Guyana
1
Latvia
1
Barbados
1
Eritrea
1
Authors & Publishers
Publication Years
Category
Countries
4842
Clinical Guidelines
829
Public Health
691
Women & Child Health
674
Key Resources
589
Capacity Building
249
Pharmacy & Technologies
107
Annual Report MEDBOX
3
Toolboxes
Mental Health
1049
COVID-19
993
HIV
848
Disability
629
TB
602
Planetary Health
550
Caregiver
363
Conflict
360
AMR
359
Ebola
344
Rapid Response
322
NTDs
298
NCDs
272
Global Health Education
271
Refugee
269
Health Financing Toolbox
219
Pharmacy
207
Natural Hazards
198
Zika
91
Social Ethics
87
Cholera
73
Specific Hazards
65
Polio
56
Typhoon
6
Health Financing
4
South Sudan
2
Patient-centred care (PCC) is a pillar of quality health services, where decision-making power is shared between the clinician and the patient. Although, this approach could be adopted with easiness in high income settings or in countries with unified health systems, in settings such as Peru, where ...
Climate change, conflict, COVID-19, and gender inequality impacts food security globally. Together with the Ukraine conflict, the food crisis across the world is worsening. UN Women’s Zero Hunger Sustainable Development Goal Map shows that 49.7% o...
This profile is part of a series of Climate Risk Country Profiles developed by the World Bank Group (WBG). The country profile
synthesizes most relevant data and information on climate change, disaster risk reduction, and adaptation actions and policies
at the country level. The country profile se...
This profile is part of a series of Climate Risk Country Profiles developed by the World Bank Group (WBG). The country profile
synthesizes most relevant data and information on climate change, disaster risk reduction, and adaptation actions and policies
at the country level. The country profile se...
These guidelines deal specifically with water, sanitation and hygiene, and are designed to be used in schools in low-cost settings in low- and medium-resource countries to:
• assess prevailing situations and plan for required improvements;
• develop and reach essential safety standards as a f...
Cotonou declaration on buruli ulcer
recommended
Cotonou Declaration oBuruli Ulcer
Cotonou, Benin, 30 March 2009
Neglected tropical diseases kill, weaken or incapacitate millions of people every year, causing permanent physical suffering, social stigmatization and reduced productive capacity. Buruli ulcer, one such disease, causes immense suffer...
The world faces grave consequences from the lack of available mental health services and treatment. Mental illness impacts every country, culture and community, with the World Health Organization (WHO) stating that 10% of the global burden of disease is related to mental, neurological and substance ...
Chikungunya virus (CHIKV) is currently one of the most relevant arboviruses to public health. It is a member of the Togaviridae family and alphavirus genus and causes an arthritogenic disease known as chikungunya fever (CHIKF). It is characterized by a multifaceted disease, which is distinguished fr...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
In an era of digital, democratic, societal and political change, communication has become more than ever a gateway for revolutionary ideas and initiatives, capable of creating stronger, more informed and more engaged communities than ever before. The emergence of ethical journalism has become centra...
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical ..., and operational challenges of the clinical trials of fexinidazole. The screening of the Drugs for Neglected Diseases initiative (DNDi) HAT-library by the Swiss TPH had singled out fexinidazole, originally developed by Hoechst (now Sanofi), as the most promising of a series of over 800 nitroimidazoles and related molecules. In cell culture, fexinidazole has an IC50 of around 1 µM against Trypanosoma brucei and is more than 100-fold less toxic to mammalian cells. In the mouse model, fexinidazole cures both the first, haemolymphatic, and the second, meningoencephalitic stage of the infection, the latter at 100 mg/kg twice daily for 5 days. In patients, the clinical trials managed by DNDi and supported by Swiss TPH mainly conducted in the Democratic Republic of the Congo demonstrated that oral fexinidazole is safe and effective for use against first- and early second-stage sleeping sickness. Based on the positive opinion issued by the European Medicines Agency in 2018, the WHO has released new interim guidelines for the treatment of HAT including fexinidazole as the new therapy for first-stage and non-severe second-stage sleeping sickness caused by Trypanosoma brucei gambiense (gHAT). This greatly facilitates the diagnosis and treatment algorithm for gHAT, increasing the attainable coverage and paving the way towards the envisaged goal of zero transmission by 2030.
Schistosomiasis is a helminthic infection and one of the neglected tropical diseases (NTDs). It is caused by blood flukes of the genus Schistosoma. It is an important public health problem, particularly in poverty-stricken areas, especially those within the tropics and subtropics. It is estimated th...
Treatment of second-stage gambiense human African trypanosomiasis relied on toxicarsenic-based derivatives for over 50 years. The availability and subsequent use of eflornithine,initially in monotherapy and more recently in combination with nifurtimox (NECT), has drasticallyimproved the pro...
The twentieth century ended with human African trypanosomiasis (HAT) epidemics raging across many parts of Africa. Resistance to existing drugs was emerging, and many programs aiming to contain the disease had ground to a halt, given previous success against HAT and the competing priorities associat...
The control of schistosomiasis was a high priority in China soon after the founding of the People’s Republic of China in 1949, and schistosomiasis japonica was largely brought under control through 7 decades of effort. However, great challenges still exist to completely eliminate schistosomiasis f...
